2015Acta OphthalmologicaRequires access

The changes of the retinal layers in diabetic patients without retinopathy

Joana Ferreira, L. Costa, Rita Pinto Proença, André Vicente, João Paulo Cunha, Luís Abegão Pinto

Open publisher page 0 citations

Abstract

Summary Diabetic retinopathy is considered to be a neurovascular disease. But in fact, retinal neurodegeneration is present before any microcirculatory abnormalities can be detected in ophthalmoscopic examination. We know this from functional studies documenting electroretinogram abnormalities, loss of dark adaptation, contrast sensitivity and color vision and abnormal microperimetry occur before any vascular abnormality is detected. Novel imaging devices have allowed this pre‐vascular damage to be quantified in a non‐invasive and reproducible way using spectral domain optical coherence tomography (SD‐OCT) that allows in vivo retinal layer thickness measurement. The extent to which this new technology can be used in the clinical setting for early screening in diabetic retinopathy will be the focus of this lecture. The review of the state of the art in this exciting new field of study may prove valuable in the management of this condition.

About this research paper

What this paper is about

Summary Diabetic retinopathy is considered to be a neurovascular disease. But in fact, retinal neurodegeneration is present before any microcirculatory abnormalities can be detected in ophthalmoscopic examination. We know this from functional studies documenting electroretinogram abnormalities, loss of dark adaptation, contrast sensitivity and color vision and abnormal microperimetry occur before any vascular abnormality is detected. Novel imaging devices have allowed this pre‐vascular damage to be quantified in a non‐invasive and reproducible way using spectral domain optical coherence tomography (SD‐OCT) that allows in vivo retinal layer thickness measurement. The extent to which this new technology can be used in the clinical setting for early screening in diabetic retinopathy will be the focus of this lecture. The review of the state of the art in this exciting new field of study may prove valuable in the management of this condition.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Summary Diabetic retinopathy is considered to be a neurovascular disease. But in fact, retinal neurodegeneration is present before any microcirculatory abnormalities can be detected in ophthalmoscopic examination. We know this from functional studies documenting electroretinogram abnormalities, loss of dark adaptation, contrast sensitivity and color vision and abnormal microperimetry occur before any vascular abnormality is detected. Novel imaging devices have allowed this pre‐vascular damage to be quantified in a non‐invasive and reproducible way using spectral domain optical coherence tomography (SD‐OCT) that allows in vivo retinal layer thickness measurement. The extent to which this new technology can be used in the clinical setting for early screening in diabetic retinopathy will be the focus of this lecture. The review of the state of the art in this exciting new field of study may prove valuable in the management of this condition.

Key concepts: Diabetic retinopathy, Retinal, Ophthalmology, Medicine, Optometry, Retinopathy, Diabetes mellitus, Endocrinology

Related papers

Back to paper searchBrowse research topicsOriginal source
The changes of the retinal layers in diabetic patients without retinopathy — Research Paper | ScholarLens